Goldman Sachs Group »

Drugs Made In Amer Acqutn shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 120k 10.27
2025-03-31 $1.2M 120k 10.02

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Drugs Made In Amer Acqutn

Karpus Investment Management
Vivaldi Asset Management
Polar Securities
Glazer Capital
Westchester Capital Management
Hudson Bay Capital Management
Wolverine Asset Management
Mizuho Securities Usa
Aristeia Capital
D. E. Shaw & Co
Heights Capital Management
Radcliffe Capital Management
LMR Partners
Boothbay Fund Management
Atw Spac Management

View all funds holding Drugs Made In Amer Acqutn